Compare Organon Pharma Indonesia Tbk. (SCPI) vs Sumber Global Energy Tbk. (SGER) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Organon Pharma Indonesia Tbk. vs Sumber Global Energy Tbk. — how do they compare? Organon Pharma Indonesia Tbk. trades at Rp29,000 (market cap 104.4B), while Sumber Global Energy Tbk. trades at Rp680 (market cap 11.22T, 57.35M 24h volume). The key difference: Sumber Global Energy Tbk. is far larger — about 107.5× Organon Pharma Indonesia Tbk.'s market cap. Which is the better fit depends on your goals.
| SCPI | SGER | |
|---|---|---|
Market Cap | 104.4B | 11.22T |
Volume | — | 57.35M |
Lot | — | 573.49K |
Turnover | — | 38.8B |
Average Price | — | 676.62 |
Value | — | 38.8B |
Indicative Equilibrium Price | — | 680 |
Indicative Equilibrium Volume | — | 2.87K |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Organon Pharma Indonesia Tbk.
PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Read more on SCPI →About Sumber Global Energy Tbk.
PT Sumber Global Energy Tbk (the Company) was established based on Notarial Deed No. 7 datedMarch 17, 2008 of Sri Hidianingsih, S.H., a public notary in Jakarta. The Company commenced operations in 2011.
Read more on SGER →
